The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Abstract
Identification and characterization of antigen-specific T lymphocytes during the course of an immune response is tedious and indirect. To address this problem, the peptide-major histocompatability complex (MHC) ligand for a given population of T cells was multimerized to make soluble peptide-MHC tetramers. Tetramers of human lymphocyte antigen A2 that were complexed with two different human immunodeficiency virus (HIV)-derived peptides or with a peptide derived from influenza A matrix protein bound to peptide-specific cytotoxic T cells in vitro and to T cells from the blood of HIV-infected individuals. In general, tetramer binding correlated well with cytotoxicity assays. This approach should be useful in the analysis of T cells specific for infectious agents, tumors, and autoantigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies can estimate the extent of CMV “obsession” by identifying antigen-specific cells using peptide-MHC class-I or class-II multimers (Altman et al. 1996; Davis et al. 2011).”
From Is immunosenescence influenced by our lifetime “dose” of exercise? (2016) · cites this paper as Altman et al. 1996
Citations
Cites
Handbook of Experimental Immunology.
Denman, A. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-6-1376_1 · Cited by 2,414
HANDBOOK OF EXPERIMENTAL IMMUNOLOGY
Holborow, E. J. (1968) · Journal of Clinical Pathology · doi:10.1136/jcp.21.4.534-c · Cited by 678
Garboczi, D. N., Hung, D. T., & Wiley, D. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3429 · Cited by 671
Schatz, P. J. (1993) · Nature Biotechnology · doi:10.1038/nbt1093-1138 · Cited by 585
Antigen-Specific Development of Primary and Memory T Cells in Vivo
McHeyzer‐Williams, M. G., & Davis, M. M. (1995) · Science · doi:10.1126/science.7535476 · Cited by 439
Self-citationKo, H. S., Fu, S. M., WINCHESTER, R. J., Yu, D. T. Y., & Kunkel, H. G. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.150.2.246 · Cited by 439
Nixon, D. F., Townsend, A., Elvin, J. G., Rizza, C. R., Gallwey, J., & McMichael, A. J. (1988) · Nature · doi:10.1038/336484a0 · Cited by 431
Self-citationMatsui, K., Boniface, J. J., Steffner, P., Reay, P. A., & Davis, M. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12862 · Cited by 425
Self-citationCarmichael, A. J., Jin, X., Sissons, P., & Borysiewicz, L. K. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.2.249 · Cited by 418
Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans.
Hoffenbach, A., Langlade‐Demoyen, P., Dadaglio, G., VILMER, E., Michel, F., Mayaud, C. M., Autran, B., & Plata, F. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.2.452 · Cited by 304
Flagged first, then by citations
2 of the 39 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- Hayakawa K., Ishii R., Yamasaki K., Kishimoto T., Hardy R. R., ibid. 84, 1379 (1987);
- Schatz P. J., Biotechnology 11, 1138 (1993).
- Johnson R. P., et al., ibid. 147, 1512 (1991).
- Koup R. A., et al., ibid. 174, 1593 (1991).
- Tripp R. A., Hou S., Doherty P. C., ibid. 154, 5870 (1995);
Cited by
Sorted by citations
Items 201–300 of 1,007
Tracking epitope-specific T cells
Moon, J. J., Chu, H., Hataye, J. M., Pagán, A. J., Pepper, M., McLachlan, J. B., Zell, T., & Jenkins, M. K. (2009) · Nature Protocols · doi:10.1038/nprot.2009.9 · Cited by 288
“pMHC tetramers are comprised of the actual ligands recognized by the TCRs of epitope-specific T cells, so in theory they should bind all epitope-specific T cells within a tissue sampl”
BackgroundHipp, M., Hilf, N., Walter, S., Werth, D., Brauer, K. M., Radsak, M. P., Weinschenk, T., Singh‐Jasuja, H., & Brossart, P. (2008) · Blood · doi:10.1182/blood-2007-02-075945 · Cited by 288
Measuring the diaspora for virus-specific CD8 + T cells
Marshall, D. R., Turner, S. J., Belz, G. T., Wingo, S., Andreansky, S. S., Sangster, M. Y., Riberdy, J. M., Liu, T., Tan, M., & Doherty, P. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101132698 · Cited by 285
Lee, K.-H., Wang, E., Nielsen, M.-B., Wunderlich, J. R., Migueles, S. A., Connors, M., Steinberg, S. M., Rosenberg, S. A., & Marincola, F. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6292 · Cited by 285
“Tetrameric HLA/ peptide complexes (tHLA) allow for direct measurement of epitope-specific T cell precursor frequency (TCPF) without in vitro manipulation ( 7 ).”
BackgroundInfluentialImmunology at the Maternal-Fetal Interface: Lessons for T Cell Tolerance and Suppression
Mellor, A. L., & Munn, D. H. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.367 · Cited by 286
Shankar, P., Russo, M. L., Harnisch, B. A., Patterson, M., Skolnik, P. R., & Lieberman, J. (2000) · Blood · doi:10.1182/blood.v96.9.3094 · Cited by 285
Evidence of premature immune aging in patients thymectomized during early childhood
Sauce, D., Larsen, M., Fastenackels, S., Duperrier, A., Keller, M., Grubeck-Loebenstein, B., Ferrand, C., Debré, P., Sidi, D., & Appay, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39269 · Cited by 278
Rogers, P., Dubey, C., & Swain, S. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2338 · Cited by 284
“The phenoytpe of T cells recovered from our model is very similar to that of cells that have been activated in vivo in response to Ag (24, 39, 40).”
ResultHarari, A., Vallelian, F., Meylan, P. R., & Pantaleo, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1037 · Cited by 284
Masopust, D., Vezys, V., Usherwood, E. J., Cauley, L. S., Olson, S., Marzo, A. L., Ward, R. L., Woodland, D. L., & Lefrançois, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4875 · Cited by 281
“Tetramers were generated, as previously described (32, 33).”
MethodWhat is Good’s syndrome? Immunological abnormalities in patients with thymoma
Kelleher, P., & Misbah, S. A. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.56.1.12 · Cited by 282
Accessing Complexity: The Dynamics of Virus-Specific T Cell Responses
Doherty, P. C., & Christensen, J. P. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.561 · Cited by 279
Understanding the drivers of MHC restriction of T cell receptors
Gruta, N. L. L., Gras, S., Daley, S. R., Thomas, P. G., & Rossjohn, J. (2018) · Nature reviews. Immunology · doi:10.1038/s41577-018-0007-5 · Cited by 283
Immunotherapy through TCR gene transfer
Kessels, H. W. H. G., Wolkers, M. C., van den Boom, M. D., van der Valk, M. A., & Schumacher, T. N. (2001) · Nature Immunology · doi:10.1038/ni1001-957 · Cited by 278
“Soluble allophycocyanin-labeled H-2D b tetramers were produced as describe”
MethodAutoreactive CD8 T cells associated with β cell destruction in type 1 diabetes
Pinkse, G. G. M., Tysma, O. M. H., van Bergen, C. A. M., Kester, M. G. D., OSSENDORP, F. A., van Veelen, P. A., Keymeulen, B., Pipeleers, D., Drijfhout, J. W., & Roep, B. O. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508621102 · Cited by 282
Gratama, J. W., van Esser, J. W. J., Lamers, C. H. J., Tournay, C., Löwenberg, B., Bolhuis, R. L. H., & Cornelissen, J. J. (2001) · Blood · doi:10.1182/blood.v98.5.1358 · Cited by 277
Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Rudawski, I., Prüß, A., Gratama, J.-W. C., Volkmer, R., Ewert, R., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340637 · Cited by 277
Hanon, E., Hall, S., Taylor, G. P., Saito, M., Davis, R., Tanaka, Y., Usuku, K., Osame, M., Weber, J. N., & Bangham, C. R. M. (2000) · Blood · doi:10.1182/blood.v95.4.1386.004k22_1386_1392 · Cited by 276
Bachmann, M. F., Wolint, P., Schwarz, K., Jäger, P., & Oxenius, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4686 · Cited by 284
Ablation of CD8 and CD4 T Cell Responses by High Viral Loads
Fuller, M. J., & Zajac, A. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.477 · Cited by 276
Rushbrook, S., Ward, S. M., Unitt, E., Vowler, S. L., Lucas, M., Klenerman, P., & Alexander, G. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7852-7859.2005 · Cited by 274
“tetramers were prepared as previously described (3) and included tetramers”
MethodSelin, L. K., Lin, M. Y., Kraemer, K. A., Pardoll, D. M., Schneck, J. P., Varga, S. M., Santolucito, P. A., Pinto, A. K., & Welsh, R. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80147-8 · Cited by 275
Schumacher, T. N. (2002) · Nature reviews. Immunology · doi:10.1038/nri841 · Cited by 276
“Because TCR-modified T cells can readily be visualized with MHC TETRAMERS”
BackgroundMicrobiota-Induced Type I Interferons Instruct a Poised Basal State of Dendritic Cells
Schaupp, L., Muth, S., Rogell, L., Kofoed-Branzk, M., Melchior, F., Lienenklaus, S., Ganal-Vonarburg, S. C., Klein, M., Guendel, F., Hain, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.022 · Cited by 263
IL-21 Influences the Frequency, Phenotype, and Affinity of the Antigen-Specific CD8 T Cell Response
Li, Y., Bleakley, M., & Yee, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2261 · Cited by 274
“PE- or allophycocyanin-labeled M27-MHC-tetramer and G154-MHC-tetramers were produced in the immune monitoring laboratory at the Fred Hutchinson Cancer Center based on previously described protocols (14).”
MethodDifferential contributions of central and effector memory T cells to recall responses
Roberts, A. D., Ely, K. H., & Woodland, D. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050137 · Cited by 277
“The NP324‐332/Kb tetramer was generated by the Molecular Biology Core Facility at the Trudeau Institute ( 46 ) and CCL19-Fc, a gift from S. Krautwald, was used to identify CCR7� cells (47).”
MethodGray, C. M., Lawrence, J., Schapiro, J., Altman, J. D., Winters, M. A., Crompton, M., Loi, M., Kundu‐Raychaudhuri, S., Davis, M. M., & Merigan, T. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1780 · Cited by 270
“With the introduction of peptide/MHC tetrameric complexes (5), it became apparent that the frequency of Ag-specific cells was consistently higher than that shown by limiting dilution analysis.”
BackgroundMethodInfluentialSelf-citationDaniëls, M. A., & Jameson, S. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.335 · Cited by 269
“Using standard procedures, K b /peptide multimeric complexes were synthesized bearing each of these peptides (16, 18).”
BackgroundMethodGea‐Banacloche, J., Migueles, S. A., Martino, L., Shupert, W. L., McNeil, A. C., Sabbaghian, M. S., Ehler, L. A., Prussin, C., Stevens, R. A., Lambert, L., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1082 · Cited by 267
“cells specific for a given peptide (13).”
ResultSelf-citationWolint, P., Betts, M. R., Koup, R. A., & Oxenius, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031799 · Cited by 262
Kuroda, M. J., Schmitz, J. E., Charini, W. A., Nickerson, C. E., Lifton, M. A., Lord, C. I., Forman, M. A., & Letvin, N. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5127 · Cited by 265
Chen, W., Norbury, C. C., Cho, Y., Yewdell, J. W., & Bennink, J. R. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1319 · Cited by 264
“The rekindled interest is also due to technological advances in T cell quantitation, such as the introduction of intracellular cytokine staining (ICS; reference 13) and MHC-peptide tetramers (14).”
BackgroundMutis, T., Gillespie, G. M. A., Schrama, E., Falkenburg, J. H. F., Moss, P. A. H., & Goulmy, E. (1999) · Nature Medicine · doi:10.1038/10563 · Cited by 264
“Folded monomeric complexes were biotinylated using BirA enzyme and were then purified by gel filtration and ion exchange as describe”
MethodSelf-citationRees, W. A., Bender, J., Teague, T. K., Kedl, R. M., Crawford, F., Marrack, P., & Kappler, J. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9781 · Cited by 263
McMichael, A. J., & O’Callaghan, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1367 · Cited by 263
Self-citationKuroda, M. J., Schmitz, J. E., Barouch, D. H., Craiu, A., Allen, T. M., Sette, A., Watkins, D. I., Forman, M. A., & Letvin, N. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1373 · Cited by 262
“who described a homogeneous phenotypic memory type profile (CD45RO1 and CD62L2) for their MHC class I–peptide binding cells (1).”
BackgroundInfluentialSelf-citationMemory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung
Chen, H. D., Fraire, A. E., Joris, I., Brehm, M. A., Welsh, R. M., & Selin, L. K. (2001) · Nature Immunology · doi:10.1038/ni727 · Cited by 259
“Developments in the identification of antigen-specific T cell response”
BackgroundButterfield, L. H., Ribas, A., Dissette, V. B., Amarnani, S. N., Vu, H. T., Oseguera, D. K., Wang, H.-J., Elashoff, R. M., McBride, W. H., Mukherji, B., et al. (2003) · PubMed · Cited by 255
T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?
Mongkolsapaya, J., Duangchinda, T., Dejnirattisai, W., Vasanawathana, S., Avirutnan, P., Jairungsri, A., Khemnu, N., Tangthawornchaikul, N., Chotiyarnwong, P., Sae-Jang, K., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3821 · Cited by 253
“Tetramers were prepared as described previously (15).”
Self-citationWu, J. D., Groh, V., & Spies, T. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1236 · Cited by 257
“Tetramers of polymorphic MHC class I- or class II-peptide complexes have been widely used as high avidity binding reagents to detect Ag-specific T cells (31, 32, 35, 36).”
MethodCochran, J. R., Cameron, T. O., & Stern, L. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)80177-6 · Cited by 256
“Extracellular antibody-induced clustering Valitutti et al. (1995) observed that at low antigen densi-of TCR complexes (Bekoff et al., 1986; Janeway, 1995) ties, single MHC-peptide complexes serially engagedor of chimeric constructs carrying TCR cytoplasmic domultiple TCR molecules, using…”
Andersen, M. H., Pedersen, L. Ø., Capeller, B., Bröcker, E. B., Becker, J. C., & Straten, P. T. (2001) · PubMed · Cited by 255
Goulder, P., Altfeld, M. A., Rosenberg, E. S., Nguyen, T. H. O., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Muckerjee, J. S., Phillips, M. N., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.181 · Cited by 255
Self-citationLeishman, A. J., Naidenko, O. V., Attinger, A., Koning, F., Lena, C. J., Xiong, Y., Chang, H., Reinherz, E. L., Kronenberg, M., & Cheroutre, H. (2001) · Science · doi:10.1126/science.1063564 · Cited by 255
Vaccination of Cancer Patients Against Telomerase Induces Functional Antitumor CD8+ T Lymphocytes
Vonderheide, R. H., Domchek, S. M., Schultze, J. L., George, D. J., Hoar, K. M., Chen, D.-Y., Stephans, K. F., Masutomi, K., Loda, M. F., Xia, Z., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0620-3 · Cited by 255
“Soluble HLA-A2 tetramers were prepared with immunizing peptides and 2-microglobulin as described (25), conjugated to phycoerythrin, and validated using peptide-specific CTLs as described (14).”
MethodBelz, G. T., Xie, W., Altman, J. D., & Doherty, P. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.8.3486-3493.2000 · Cited by 253
“Virus-specific CD8(1) T cells were identified using tetrameric complexes of the H-2D glycoprotein and peptides (1) derived from the NP ASNENMETM (23) and PA SSLENFRAYV,”
BackgroundSelf-citationClark, R. E., Dodi, I. A., Hill, S. C., Lill, J. R., Aubert, G., Macintyre, A. R., Rojas, J. M., Bourdon, A., Bonner, P. L. R., Wang, L., et al. (2001) · Blood · doi:10.1182/blood.v98.10.2887 · Cited by 253
de Carvalho, L. H., Sano, G., Hafalla, J. C. R., Morrot, A., de Lafaille, M. A. C., & Zavala, F. P. (2002) · Nature Medicine · doi:10.1038/nm0202-166 · Cited by 252
“SYVPSAEQI-specific H2K d tetramer was obtained from the NIH Tetramer Facility or prepared as describe”
MethodEbert, P. J. R., Jiang, S., Xie, J., Li, Q.-J., & Davis, M. M. (2009) · Nature Immunology · doi:10.1038/ni.1797 · Cited by 251
“ATPase–I-E k and GP–I-E k monomers were prepared, biotinylated and made into tetramers as describe”
Self-citationAllen, T. M., Vogel, T. U., FULLER, D. H., Mothé, B. R., Steffen, S. R., Boyson, J. E., Shipley, T., Fuller, J., Hanke, T., Sette, A., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.9.4968 · Cited by 251
“Once the PCR products were cloned into an expression vector using NdeI and BamHI cloning sites (52), the rhesus MHC molecules were expressed and then folded with human b2m and peptide.”
MethodSelf-citationT-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes
Kula, T., Dezfulian, M. H., Wang, C. I., Abdelfattah, N. S., Hartman, Z. C., Wucherpfennig, K. W., Lyerly, H. K., & Elledge, S. J. (2019) · Cell · doi:10.1016/j.cell.2019.07.009 · Cited by 250
“Classic approaches for understanding T cell specificity rely on readouts of T cell function, which include assays for cytotoxicity, cytokine release, and proliferation in the presence of candidate antigens (Sharma and Holt, 2014), augmented by peptide-MHC tetramers for antigen-specific populations (Altman et al., 1996…”
BackgroundGreten, T. F., Slansky, J. E., Kubota, R., Soldan, S. S., Jaffee, E. M., Leist, T. P., Pardoll, D. M., Jacobson, S., & Schneck, J. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7568 · Cited by 247
Lee, P. P., Wang, F., Kuniyoshi, J., Rubio, V., Stuge, T. B., Groshen, S. G., Gee, C., Lau, R., Jeffery, G., Margolin, K. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3836 · Cited by 245
Immunology of hepatitis B infection
Jung, M., & Pape, G. R. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00172-4 · Cited by 243
Cytomegalovirus Infection: A Driving Force in Human T Cell Immunosenescence
KOCH, S., LARBI, A., ÖZCELIK, D., SOLANA, R., GOUTTEFANGEAS, C., ATTIG, S., WIKBY, A., STRINDHALL, J., FRANCESCHI, C., & PAWELEC, G. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.043 · Cited by 242
Ouyang, Q., Wagner, W. M., Wikby, A., Walter, S., Aubert, G., Dodi, A. I., Travers, P. J., & Pawelec, G. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1024580531705 · Cited by 239
“HLA class I/peptide tetramers were synthesized as described previously by others ( 18 ).”
Accelerated immune senescence and HIV-1 infection
APPAY, V, ALMEIDA, J., SAUCE, D., AUTRAN, B., & PAPAGNO, L. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.12.003 · Cited by 236
Ouyang, Q., Wagner, W. M., Voehringer, D., Wikby, A., Klatt, T., Walter, S., Müller, C. A., Pircher, H., & Pawelec, G. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00134-7 · Cited by 238
Wang, G. C., Dash, P., McCullers, J. A., Doherty, P. C., & Thomas, P. G. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003647 · Cited by 238
Schuurhuis, D. H., Ioan‐Facsinay, A., Nagelkerken, B., Schip, J. J. V. D. P.-V., Sedlik, C., Melief, C. J. M., Verbeek, J. S., & OSSENDORP, F. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2240 · Cited by 238
Vance, R. E., Jamieson, A. M., & Raulet, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1801 · Cited by 238
“1804 Recognition of Qa-1 b by CD94/NKG2C and CD94/NKG2E were generated and used as described previously (9, 39), except”
MethodDirected evolution of a stable scaffold for T-cell receptor engineering
Shusta, E. V., Holler, P. D., Kieke, M. C., Kranz, D. M., & Wittrup, K. D. (2000) · Nature Biotechnology · doi:10.1038/77325 · Cited by 237
“In an enzyme-linked immunosorbent assay (ELISA)-based multivalent pMH”
MethodJenkins, M. K., Chu, H., McLachlan, J. B., & Moon, J. J. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101253 · Cited by 256
Identification of MAGE-3 Epitopes Presented by HLA-DR Molecules to CD4+ T Lymphocytes
Chaux, P., Vantomme, V., Stroobant, V., Thielemans, K., Corthals, J., Luiten, R. M., Eggermont, A. M. M., Boon, T., & van der Bruggen, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.767 · Cited by 234
“Another possibility, which narrows the analysis to certain epitopes, is the use of a set of relevant peptides that can be used either to select and amplify peptide-specific T cells in vitro or to label directly T cell receptors with soluble HLA tetramers presenting the relevant peptide (50, 51).”
BackgroundLoss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals
Paiardini, M., Cervasi, B., Albrecht, H., Muthukumar, A., Dunham, R. M., Gordon, S. N., Radziewicz, H., Piedimonte, G., Magnani, M., Montroni, M., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2900 · Cited by 233
“Tetrameric HLA class I molecules were produced as previously described (25).”
MethodSelf-citationTrudeau, J. D., Kelly-Smith, C., Verchere, C. B., Elliott, J. F., Dutz, J. P., Finegood, D. T., Santamaría, P., & Tan, R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200316409 · Cited by 232
Belyakov, I. M., Hel, Z., Kelsall, B. L., Kuznetsov, V. A., Ahlers, J. D., Nacsa, J., Watkins, D. I., Allen, T. M., Sette, A., Altman, J. D., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1320 · Cited by 232
“Soluble tetrameric Mamu-A a 01/CM9 complex conjugated to PE-labeled streptavidin prepared as describe”
Self-citation[26] Biotinylation of proteins in vivo and in vitro using small peptide tags
Cull, M. G., & Schatz, P. J. (2000) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)26068-0 · Cited by 230
Allen, T. M., Sidney, J., del Guercio, M., Glickman, R. L., Lensmeyer, G. L., Wiebe, D. A., DeMars, R., Pauza, C. D., Johnson, R. P., Sette, A., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6062 · Cited by 230
“This epitope can now be used to develop epitope-based vaccines, to detect viral escape mutants, or to form soluble peptide-MHC dimers or tetramers (77, 78) for the identification and characterization of peptide-specific CTL.”
Heemskerk, B., Kvistborg, P., & Schumacher, T. N. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.333 · Cited by 239
“The detection of antigen-specific Tcells independent of their functional capacities first became possible when Altman et al (1996) demonstrated that fluorescently labelled multimers of MHC molecules containing a peptide of interest could be used to specifically detect T cells that recognize this…”
Martin, D. L., Weatherly, D. B., Laucella, S. A., Cabinian, M. A., Crim, M. T., Sullivan, S., Heiges, M., Craven, S. H., Rosenberg, C. S., Collins, M. H., et al. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020077 · Cited by 228
“focused on a small number of epitopes [2–4], and examination”
BackgroundWard, J. P., Gubin, M. M., & Schreiber, R. D. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.01.001 · Cited by 232
“…human tumors identified Coulie et al. (1995) and Wolfel et al. (1995) 1996 Use of peptide–MHC tetramers to analyze antigen-specific T cells Altman et al. (1996) Antitumor activity of anti-CTLA-4 demonstrated in mice Leach, Krummel, and Allison (1996) 1997 Use of SEREX to identify the…”
BackgroundBim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis
Wojciechowski, S., Tripathi, P., Bourdeau, T., Acero, L. F., Grimes, H. L., Katz, J. D., Finkelman, F. D., & Hildeman, D. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070618 · Cited by 227
Rha, M., Jeong, H. W., Ko, J. H., Choi, S. J., Seo, I., Lee, J. S., Sa, M., Kim, A. R., Joo, E., Ahn, J. Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.12.002 · Cited by 227
“The limitation of stimulation-based functional assays can be overcome by using major histocompatibility complex class I (MHC class I) multimer techniques (Altman et al., 1996).”
Lieberman, J., Shankar, P., Manjunath, N., & Andersson, J. (2001) · Blood · doi:10.1182/blood.v98.6.1667 · Cited by 226
Single-cell mass cytometry for analysis of immune system functional states
Bjornson, Z. B., Nolan, G. P., & Fantl, W. J. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.004 · Cited by 227
“The tetramer can then be detected by flow cytometry via the fluorescent label [82,83].”
Halle, S., Keyser, K. A., Stahl, F. R., Busche, A., Marquardt, A., Zheng, X., Galla, M., Heissmeyer, V., Heller, K., Boelter, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.01.010 · Cited by 231
“After 6–8 days, MCMV-specific CTLs were isolated by tetramer staining (Altman et al., 1996).”
Coles, R. M., Mueller, S. N., Heath, W. R., Carbone, F., & Brööks, A. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.834 · Cited by 225
CTL Fail to Accumulate at Sites of HIV-1 Replication in Lymphoid Tissue
Connick, E., Mattila, T. L., Folkvord, J. M., Schlichtemeier, R., Meditz, A. L., Ray, M., McCarter, M. D., MaWhinney, S., Hage, A., White, C., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6975 · Cited by 224
Trautmann, L., Rimbert, M., Echasserieau, K., Saulquin, X., Neveu, B., Déchanet‐Merville, J., Cerundolo, V., & Bonneville, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6123 · Cited by 224
“Soluble pMHC monomer NLV/A2 was generated as described (24).”
MethodAlmeida, J. R., Sauce, D., Price, D. A., Papagno, L., Shin, S. Y., Moris, A., Larsen, M., Pancino, G., Douek, D. C., Autran, B., et al. (2009) · Blood · doi:10.1182/blood-2009-02-206557 · Cited by 224
The Role of β7 Integrins in CD8 T Cell Trafficking During an Antiviral Immune Response
Lefrançois, L., Parker, C. M., Olson, S., Müller, W., Wagner, N., & Puddington, L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1631 · Cited by 224
Dunbar, P. R., Ogg, G. S., Chen, J., Rust, N. A., van der Bruggen, P., & Cerundolo, V. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70161-7 · Cited by 224
“Complexes were biotinylated and bound to phycoerythrin (PE)-labelled streptavidin at a 4:1 ratio, to form an A2–matrix tetramer [1].”
MethodKita, H., Matsumura, S., He, X.-S., Ansari, A. A., Lian, Z.-X., Van de Water, J., Coppel, R. L., Kaplan, M. M., & Gershwin, M. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214698 · Cited by 222
Palermo, B., Campanelli, R., Garbelli, S., Mantovani, S., Lantelme, E., Brazzelli, V., Ardigò, M., Borroni, G., Martinetti, M., Badulli, C., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01408.x · Cited by 222
Differentiation of Human CD8+ T Cells from a Memory to Memory/Effector Phenotype
Tomiyama, H., Matsuda, T., & Takiguchi, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5538 · Cited by 220
“HLA class I-peptide tetrameric complexes were synthesized as previously described (30).”
MethodKita, H., Matsumura, S., He, X.-S., Ansari, A. A., Lian, Z., de Water, J. V., Coppel, R. L., Kaplan, M. M., & Gershwin, M. E. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14698 · Cited by 222
“PDC-E2159-167-HLA A2 tetramers were generated as described (17).”
Coulie, P. G., Karanikas, V., Colau, D., Lurquin, C., Landry, C., Marchand, M., Dorval, T., Brichard, V. G., & Boon, T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161260098 · Cited by 221
Sourdive, D. J. D., Murali‐Krishna, K., Altman, J. D., Zajac, A. J., Whitmire, J. K., Pannetier, C., Kourilsky, P., Evavold, B. D., Sette, A., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.71 · Cited by 219
“We took advantage of this feature to identify virus-specific T cells by staining with Ld-NP118–126 MHC class I tetramers (25, 46).”
MethodSelf-citationCrowe, S. R., Turner, S. J., Miller, S. C., Roberts, A. D., Rappolo, R. A., Doherty, P. C., Ely, K. H., & Woodland, D. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022151 · Cited by 218
“ated by the Molecular Biology Core Facility at the Trudeau Institute as described previously ( 25 ).”
MethodChang, J., & Braciale, T. J. (2002) · Nature Medicine · doi:10.1038/nm0102-54 · Cited by 218
“MHC class I–peptide tetramers were produced as describe”
MethodHislop, A. D., Gudgeon, N. H., Callan, M. F. C., Fazou, C., Hasegawa, H., Salmon, M., & Rickinson, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2019 · Cited by 218
“I/peptide tetramers (15) and on peptide-induced cytokine release”
BackgroundMethodDetection of T-Cell Degranulation: CD107a and b
Betts, M. R., & Koup, R. A. (2004) · Methods in cell biology · doi:10.1016/s0091-679x(04)75020-7 · Cited by 215
T cell vaccines for microbial infections
Robinson, H. L., & Amara, R. R. (2005) · Nature Medicine · doi:10.1038/nm1212 · Cited by 218
“The tetramer assay directly tests samples for the frequency of CD8 T cells with a specific T cell recepto”
MethodGamadia, L. E., Rentenaar, R. J., Baars, P. A., Remmerswaal, E. B. M., Surachno, S., Weel, J. F. L., Toebes, M., Schumacher, T. N., ten Berge, I. J. M., & van Lier, R. A. W. (2001) · Blood · doi:10.1182/blood.v98.3.754 · Cited by 215
Gütgemann, I., Fahrer, A. M., Altman, J. D., Davis, M. M., & Chien, Y. (1998) · Immunity · doi:10.1016/s1074-7613(00)80571-3 · Cited by 212
Self-citationKnabel, M., Franz, T. J., Schiemann, M., Wulf, A., Villmow, B., Schmidt, B., Bernhard, H., Wagner, H., & Busch, D. H. (2002) · Nature Medicine · doi:10.1038/nm0602-631 · Cited by 211
“and major histocompatibility complex (MHC) multimer procedure”
Özdemir, E., John, L. S. S., Gillespie, G. M. A., Rowland‐Jones, S., Champlin, R. E., Molldrem, J. J., & Komanduri, K. V. (2002) · Blood · doi:10.1182/blood-2002-05-1387 · Cited by 211
Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
Frebel, H., Nindl, V., Schuepbach, R. A., Braunschweiler, T., Richter, K., Vogel, J., Wagner, C. A., Loffing‐Cueni, D., Kurrer, M. O., Ludewig, B., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121015 · Cited by 218
“as previously described (Altman et al., 1996).”
MethodRezvani, K., Grube, M., Brenchley, J. M., Sconocchia, G., Fujiwara, H., Price, D. A., Emma Gostick, D., YAMADA, K., Melenhorst, J. J., Childs, R. W., et al. (2003) · Blood · doi:10.1182/blood-2003-01-0150 · Cited by 211
Metadata
- Authors
- Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M.
- Affiliations
- Stanford Medicine (US)
- John Radcliffe Hospital (GB)
- J. D. Altman and M. G. McHeyzer-Williams, Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305-5428, USA.
- Howard Hughes Medical Institute (US)
- Corresponding author
- Davis, Mark M.
- ORCID
- Venue
- Science
- Published
- 1996-10-04
- Volume
- 274
- Issue
- 5284
- Pages
- 94-96
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2067069532
- Cited by
- 3,544
- References
- 39
- Citations by year
- 2026: 44 · 2025: 41 · 2024: 45 · 2023: 59 · 2022: 43 · 2021: 68 · 2020: 59 · 2019: 71 · 2018: 70 · 2017: 42 · 2016: 62 · 2015: 73 · 2014: 69 · 2013: 101 · 2012: 93
- FWCI
- 35.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Keywords
- antigen-specific T cells, peptide-MHC tetramers, HLA-A2, cytotoxic T lymphocytes, cytotoxicity assay, T cell phenotyping, HIV infection, tumor-specific T cells, autoantigen-specific T cells
- MeSH terms
- Amino Acid Sequence, Epitopes, Antigens, Viral, Base Sequence, Cell Line, Coloring Agents, Flow Cytometry, HIV Seropositivity, Humans, Molecular Sequence Data, Peptide Fragments, Phenotype, RNA-Directed DNA Polymerase, T-Lymphocytes, Cytotoxic, Viral Matrix Proteins, Gene Products, gag, HLA-A2 Antigen, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review